New research, published as a pre-print, suggests that semaglutide could be mass produced for $3 (about 2.35) for a monthly dose in its injectable form
In mouse microglia, a GLP-1 receptor agonist called NLY01 blocked nuclear translocation of NF-kB entirely when cells were stimulated with bacterial endotoxin
STEP 1, the largest trial with 1,961 participants, demonstrated that after 68 weeks of treatment, patients achieved an average weight loss of 14.9% compared to 2.4% with placebo
Noah Gratch, MD, FAAD is a board-certified dermatologist who specializes in treatments for acne, eczema, hyperhidrosis, rosacea, psoriasis, and skin cancer
Importantly, none of these studies incorporated imaging, physiological, or histopathological measures of lung fibrosis, precluding conclusions regarding anti-fibrotic clinical efficacy of GLP-1 agonists in pulmonary fibrosis